Global yellow fever vaccination coverage from 1970 to 2016: an adjusted retrospective analysis Freya M Shearer, BSc, Catherine L Moyes, PhD, David M.

Slides:

Advertisements

Similar presentations

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)

Advertisements

Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling study Oliver J Brady, DPhil, Hannah C Slater,

Variation in life expectancy and mortality by cause among neighbourhoods in King County, WA, USA, 1990–2014: a census tract-level analysis for the Global.

Spread of yellow fever virus outbreak in Angola and the Democratic Republic of the Congo 2015–16: a modelling study Moritz U G Kraemer, DPhil, Nuno R.

The Lancet Public Health

Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study Alejandra Castanon, MD, Rebecca Landy, PhD,

Demographic and practice factors predicting repeated non-attendance in primary care: a national retrospective cohort analysis David A Ellis, PhD, Ross.

Helen Cox, Mark P Nicol The Lancet Infectious Diseases

Global yellow fever vaccination coverage from 1970 to 2016: an adjusted retrospective analysis Freya M Shearer, BSc, Catherine L Moyes, PhD, David M.

Risk of cancer associated with residential exposure to asbestos insulation: a whole- population cohort study Dr Rosemary J Korda, PhD, Mark S Clements,

Potential for Zika virus introduction and transmission in resource-limited countries in Africa and the Asia-Pacific region: a modelling study Isaac I.

Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden.

When less is more: how many doses of PCV are enough?

Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants:

Prevalence of cerebral palsy in Uganda: a population-based study

Do air quality alerts benefit public health? New evidence from Canada

Volume 18, Issue 6, Pages (June 2017)

Global, regional, and subregional trends in unintended pregnancy and its outcomes from 1990 to 2014: estimates from a Bayesian hierarchical model Jonathan.

Safety of a killed oral cholera vaccine (Shanchol) in pregnant women in Malawi: an observational cohort study Dr Mohammad Ali, PhD, Allyson Nelson, MSPH,

Volume 389, Issue 10071, Pages (February 2017)

Prof Seena Fazel, MD, Taanvi Ramesh, MSc, Prof Keith Hawton, FMedSci

Retracted: Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment Jonathan Pearson-Stuttard, BMBCh,

Volume 389, Issue 10077, Pages (April 2017)

Access to emergency hospital care provided by the public sector in sub-Saharan Africa in 2015: a geocoded inventory and spatial analysis Paul O Ouma,

Volume 390, Issue 10113, Pages (December 2017)

The effect of explosive remnants of war on global public health: a systematic mixed- studies review using narrative synthesis Alexandra Frost, MSc, Prof.

National, regional, and global prevalence of smoking during pregnancy in the general population: a systematic review and meta-analysis Shannon Lange,

The contribution of poor and rural populations to national trends in reproductive, maternal, newborn, and child health coverage: analyses of cross-sectional.

Prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people: a systematic review and meta-analysis Ulla Beijer, PhD, Achim Wolf, MSc, Dr.

Resuscitation at birth and cognition at 8 years of age: a cohort study

Malebona Precious Matsoso, Jeanette Rebecca Hunter, Vishal Brijlal

Volume 4, Issue 6, Pages (June 2017)

Low-level lead exposure and mortality in US adults: a population-based cohort study Prof Bruce P Lanphear, MD, Stephen Rauch, MPH, Peggy Auinger, MS,

Trends in diagnosis and treatment for people with dementia in the UK from 2005 to 2015: a longitudinal retrospective cohort study Katherine Donegan,

Volume 5, Issue 11, Pages (November 2018)

Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling study Oliver J Brady, DPhil, Hannah C Slater,

Measuring health and economic wellbeing in the Sustainable Development Goals era: development of a poverty-free life expectancy metric and estimates for.

Volume 4, Issue 10, Pages (October 2017)

Cost-effectiveness of the controlled temperature chain for the hepatitis B virus birth dose vaccine in various global settings: a modelling study Nick.

Trends in infant mortality in Venezuela between 1985 and 2016: a systematic analysis of demographic data Jenny García, MSc, Prof Gerardo Correa, MSc,

Volume 392, Issue 10164, Pages (December 2018)

Risk of poor development in young children in low-income and middle-income countries: an estimation and analysis at the global, regional, and country.

Retracted: Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment Jonathan Pearson-Stuttard, BMBCh,

Volume 393, Issue 10172, Pages (February 2019)

Volume 393, Issue 10172, Pages (February 2019)

Existing and potential infection risk zones of yellow fever worldwide: a modelling analysis Freya M Shearer, BSc, Joshua Longbottom, MSc, Annie J Browne,

Elder abuse prevalence in community settings: a systematic review and meta-analysis Yongjie Yon, MA, Christopher R Mikton, PhD, Zachary D Gassoumis, PhD,

Spread of yellow fever virus outbreak in Angola and the Democratic Republic of the Congo 2015–16: a modelling study Moritz U G Kraemer, DPhil, Nuno R.

Spread of yellow fever virus outbreak in Angola and the Democratic Republic of the Congo 2015–16: a modelling study Moritz U G Kraemer, DPhil, Nuno R.

Forecasting the care needs of the older population in England over the next 20 years: estimates from the Population Ageing and Care Simulation (PACSim)

Anna J Dare, Calvin Ke, Wilson Suraweera, Peter Rodriguez, Prabhat Jha

Thank you to our diverse (but not diverse enough) reviewers

Vulnerability to snakebite envenoming: a global mapping of hotspots

Volume 392, Issue 10160, Pages (November 2018)

Antimicrobial resistance among migrants in Europe: a systematic review and meta- analysis Laura B Nellums, PhD, Hayley Thompson, MPH, Prof Alison Holmes,

Volume 4, Issue 5, Pages (May 2017)

Contributions of diseases and injuries to widening life expectancy inequalities in England from 2001 to 2016: a population-based analysis of vital registration.

The Lancet Infectious Diseases

Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment Jonathan Pearson-Stuttard, BMBCh, Bin Zhou,

Effectiveness of strategies to improve health-care provider practices in low-income and middle-income countries: a systematic review Alexander K Rowe,

Age-targeted tuberculosis vaccination in China and implications for vaccine development: a modelling study Rebecca C Harris, PhD, Tom Sumner, PhD, Gwenan.

Reducing the cardiovascular disease burden for people of all ages in the Americas region: analysis of mortality data, 2000–15 Prof Peter Lloyd-Sherlock,

Population attributable fractions for risk factors for dementia in low-income and middle- income countries: an analysis using cross-sectional survey data

Volume 376, Issue 9750, Pages (October 2010)

Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi- eligible countries: a modelling study Joke Bilcke, PhD, Marina.

Use of standardised patients to assess gender differences in quality of tuberculosis care in urban India: a two-city, cross-sectional study Benjamin.

Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study Gayatri Amirthalingam,

Effect of strikes by health workers on mortality between 2010 and 2016 in Kilifi, Kenya: a population-based cohort analysis Gerald Ong'ayo, MBChB, Michael.

Long-term outcomes of childhood sexual abuse: an umbrella review

Sickle cell disease: a new era

Presentation transcript:

Global yellow fever vaccination coverage from 1970 to 2016: an adjusted retrospective analysis Freya M Shearer, BSc, Catherine L Moyes, PhD, David M Pigott, DPhil, Oliver J Brady, DPhil, Fatima Marinho, PhD, Aniruddha Deshpande, MPH, Joshua Longbottom, MSc, Annie J Browne, MPH, Moritz U G Kraemer, DPhil, Kathleen M O'Reilly, PhD, Joachim Hombach, PhD, Sergio Yactayo, MD, Valdelaine E M de Araújo, PhD, Aglaêr A da Nóbrega, PhD, Jonathan F Mosser, MD, Jeffrey D Stanaway, PhD, Prof Stephen S Lim, PhD, Prof Simon I Hay, FMedSci, Nick Golding, DPhil, Robert C Reiner, PhD The Lancet Infectious Diseases Volume 17, Issue 11, Pages 1209-1217 (November 2017) DOI: 10.1016/S1473-3099(17)30419-X Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions

Figure 1 Yellow fever vaccination coverage from 1970 to 2016 Estimated proportion of the population across all age cohorts who have ever received a yellow fever vaccine at the beginning of each decade (and in 2016) at the second administrative level for countries at risk of yellow fever virus transmission, based on the untargeted, unbiased vaccination-targeting scenario. The Lancet Infectious Diseases 2017 17, 1209-1217DOI: (10.1016/S1473-3099(17)30419-X) Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions

Figure 2 Contemporary yellow fever vaccination coverage scenarios Estimated proportion of the population in 2016 across all age cohorts who have ever received a yellow fever vaccine at the second administrative level in countries at risk of yellow fever virus transmission. Vaccination coverage was calculated using three alternative vaccination-targeting scenarios: (A) targeted; (B) untargeted, unbiased; and (C) untargeted, biased. (D) Percentage difference in coverage between targeting scenarios A and C. The Lancet Infectious Diseases 2017 17, 1209-1217DOI: (10.1016/S1473-3099(17)30419-X) Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions

Figure 3 National yellow fever vaccination coverage by age group Estimated proportion of individuals within each age group in 2016 who have ever received a yellow fever vaccine for each country at risk of yellow fever virus transmission, based on the untargeted, unbiased vaccination-targeting scenario. Plots for the beginning of each decade from 1970 to 2010 are provided in the appendix (pp 10–11). The Lancet Infectious Diseases 2017 17, 1209-1217DOI: (10.1016/S1473-3099(17)30419-X) Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions